COMMUNIQUÉS West-GlobeNewswire

Trading by management and of close relations to management
29/11/2017
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the [...]
Management change at ALK
29/11/2017
Copenhagen, 2017-11-29 08:26 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) today announced that Helle Skov, Executive Vice President (EVP) of Product Supply and a member of ALK's Board of [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
29/11/2017
REGULATED INFORMATION GHENT, Belgium, 29 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
MedMira Reports 2017 Fourth Quarter and Year End Financial Results
29/11/2017
HALIFAX, Nova Scotia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter and year ended July 31, 2017. MedMira’s Chief Financial Officer, Markus [...]
Cesca Therapeutics Inc. Announces Proposed Public Offering of Common Stock
28/11/2017
RANCHO CORDOVA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]
VANC Pharmaceuticals Closes Oversubscribed Private Placement
28/11/2017
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. ( “VANC” or the “Company” ) (TSX-V: VANC ) (OTCQB:NUVPF) announces today that as per the news release dated October 23, 2017 it [...]
iKang Schedules 2017 Unaudited Second Quarter Earnings Release on December 14, 2017
28/11/2017
BEIJING, Nov. 28, 2017 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), major provider in China’s fast growing private preventive healthcare services market, today announced [...]
Teladoc Announces Proposed Sale of Shares of Common Stock
28/11/2017
PURCHASE, NY, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: TDOC ) (“Teladoc”) today announced a proposed offering of shares of its common stock, which includes 3,250,000 shares offered by Teladoc and 830,000 [...]
Flexion Therapeutics to Present at Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference
28/11/2017
BURLINGTON, Mass., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that Michael Clayman, M.D., President and Chief Executive Officer, and Dan Deardorf, Senior Vice President [...]
Cytori Closes Rights Offering for Gross Proceeds of $10 Million
28/11/2017
SAN DIEGO, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc . (“Cytori”) (NASDAQ: CYTX ) announced today the closing of its rights offering (the “Rights Offering”) to subscribe for units at a subscription [...]
Iovance Biotherapeutics to Present at the Evercore ISI Biopharma Catalyst/Deep Dive Conference
28/11/2017
SAN CARLOS, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Ovid Therapeutics Announces OV101 Shows Comparable PK Profile in Phase 1 Study of Adolescent Patients and Amends Phase 2 STARS Clinical Trial Protocol to Include Adolescents
28/11/2017
-- Results from the Phase 1 Clinical Trial of Adolescents with Angelman and Fragile X Syndromes Demonstrated OV101 was Well Tolerated with a Pharmacokinetic Profile Similar to Adults -- -- With Core Expertise in [...]
Emblem Announces Third Quarter 2017 Financial Results
28/11/2017
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. ( “Emblem” or the “ Company ”) (TSXV:EMC), a vertically [...]
eRAD RIS Selected by Drs Schnetler, Corbett and Partners Radiology
28/11/2017
GREENVILLE, S.C., Nov. 28, 2017 (GLOBE NEWSWIRE) -- eRAD announced today that Drs Schnetler, Corbett and Partners Radiology (SCP Radiology) has selected eRAD’s Radiology Information System (RIS) to manage its clinical [...]
Arzeda Officially Closes Series A with Total $15.2 Million to Revolutionize Chemical Production with Protein Design
28/11/2017
SEATTLE, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Arzeda , The Protein Design Company TM , today announced that it has officially closed its Series A funding round with a total investment of $15.2 million. The company raised [...]
Discovery of Innate Immune Mechanisms of a Novel Microbial-based Approach for the Treatment of Lung Cancer
28/11/2017
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc. (Qu), a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies designed to “ [...]
Irvine Facial Plastic Surgeon Distinguishes Between Lip Enhancement Options
28/11/2017
IRVINE, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- As people age, the lips become susceptible to volume loss. The lips may gradually appear thin or begin to lose their definition. In response to this common cosmetic [...]
PDC Healthcare Launches New DuraProtect™ Laser Wristbands Engineered to Deliver Greater Durability at a Lower Cost
28/11/2017
VALENCIA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- PDC Healthcare , a global leader of innovative identification and patient safety solutions, announced today the launch of DuraProtect ™, its newest line of laser [...]
Biothera Pharmaceuticals Enters Cancer Immunotherapy Clinical Trial Collaboration Agreement
28/11/2017
EAGAN, Minn., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. today announced that it has entered into a clinical trial collaboration agreement with Genentech, Inc., a member of the Roche Group, to [...]

Pages